BOOSTING ONCOLOGY EXPLORATION WITH BUILT-IN KRAS ASSAY SOLUTIONS AND RAS ASSAYS

from the fast evolving discipline of oncology research, correct and successful mutation screening is essential for creating targeted therapies. The KRAS providers Platform plays a pivotal role During this landscape by featuring complete alternatives for KRAS mutation profiling and analysis. KRAS mutations, found in approximately ninety five% of RAS